Blue Sea Capital rapidly beats hard cap with $800m healthcare-only Fund IV close
Tuesday, November 17, 2026 · first reported by AltAssets and 3 others
Blue Sea Capital, a healthcare-focused private equity firm in West Palm Beach, Florida, has closed Blue Sea Capital Fund IV and its executive fund at $800 million of aggregate commitments. That tops the $550 million target and the original $700 million hard cap. The firm said it passed the revised cap within four months of a May launch.
Fund IV is Blue Sea's first vehicle devoted solely to healthcare. It targets North American lower-middle-market companies with $5 million to $30 million of EBITDA. Its predecessor raised nearly $620 million including the executive fund.
- Firm
- Blue Sea Capital
- Fund
- Blue Sea Capital Fund IV
- Size
- $800M
- Stage
- Close
- Asset class
- Private equity
Advisers Kirkland & Ellis (fund counsel)
In the data This close in the fund closes table · Every Blue Sea Capital close
Terms Hard cap · EBITDA · Commitment · Private equity
The summary and fields above are extracted from the published reports and can contain errors. The linked articles are the source of record.
See an error?
Coverage
4 sources- AltAssetsBlue Sea Capital rapidly beats hard cap with $800m healthcare-only Fund IV close
- citybizBlue Sea Capital closes oversubscribed $800 million Fund IV, Exceeding $550 million target
- HedgeCoBlue Sea Capital closed its first Healthcare-Only fund at $800 million, above its hard cap
- Law360Kirkland-Led Blue Sea Wraps $800M Healthcare-Focused Fund
- Onex surpasses target for Onex Partners V, raises $7.15 blnPEI Private Equity
- Argonaut Private Equity raises $606 million to buy industrial businessesWSJ +2
- La Caisse leads talks for stake in Bain’s Bridge Data CentresPrivate Equity Wire
- First Circle Capital completes $26m final close for Africa Fund I to build the next generation of African fintech infrastructureDisruption Banking +3
- Blackstone eyes $8bn for third core private equity fundPrivate Equity News
- Aphias Capital closes oversubscribed debut fund at $1.05BDealroom
Got news? Send it to us →